We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Aptamer Group Plc | LSE:APTA | London | Ordinary Share | GB00BNRRP542 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.55 | 3,133,754 | 08:00:05 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.50 | 0.60 | 0.55 | 0.519 | 0.55 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 1.75M | -7.84M | -0.0168 | -0.33 | 2.57M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 15:11:55 | O | 300,000 | 0.5699 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/4/2024 | 11:54 | ALNC |  Aptamer inks new Optimer+ transplant rejection therapy partnership |
| 18/4/2024 | 10:06 | UK RNS | Aptamer Group PLC TR-1: Notification of major holdings |
| 18/4/2024 | 07:00 | UK RNS | Aptamer Group PLC Aptamer and Kairos Biotech partner for Optimer+ |
| 08/4/2024 | 14:27 | ALNC | Aptamer submits patent application for Optimer binders |
| 08/4/2024 | 07:00 | UK RNS | Aptamer Group PLC Patent submission for Optimer® binders |
| 28/3/2024 | 14:07 | UK RNS | Aptamer Group PLC Holding(s) in Company |
| 28/3/2024 | 12:29 | ALNC | EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles |
| 28/3/2024 | 07:00 | UK RNS | Aptamer Group PLC Interim Results |
| 22/3/2024 | 07:00 | UK RNS | Aptamer Group PLC Notice of Interim Results & Investor Presentation |
| 14/3/2024 | 07:00 | UK RNS | Aptamer Group PLC Investor Webinar |
Aptamer (APTA) Share Charts1 Year Aptamer Chart |
|
1 Month Aptamer Chart |
Intraday Aptamer Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 11/4/2024 | 20:18 | ☆☆ Aptamer Group - Novel Antibody Mimetics (Optimers) ☆☆ | 4,562 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 14:11:57 | 0.57 | 300,000 | 1,709.70 | O |
| 09:58:45 | 0.57 | 262,000 | 1,493.14 | O |
| 09:52:30 | 0.51 | 380,000 | 1,948.11 | O |
| 09:51:09 | 0.58 | 55,000 | 316.25 | O |
| 09:28:30 | 0.56 | 144,602 | 809.05 | O |
| Top Posts |
|---|
Posted at 19/4/2024 09:20 by Aptamer Daily Update Aptamer Group Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker APTA. The last closing price for Aptamer was 0.55p.Aptamer currently has 467,343,673 shares in issue. The market capitalisation of Aptamer is £2,570,390. Aptamer has a price to earnings ratio (PE ratio) of -0.33. This morning APTA shares opened at 0.55p |
Posted at 28/3/2024 07:42 by timbo003 We will have to wait and see, but given the current share price. I suspect that a dilutive placing is already priced in. |
Posted at 12/3/2024 14:41 by bones698 Icac totally agree the lack of revenue delivering contracts will mean a cash raise soon is inevitable and with it another drop in the share price to that level likely to be 0.5p unless it gets forward sold into in which case it could drop even lower. Unfortunately in this sector progress is painfully slow and with apta tye deals are so small in size they are hardly worth the huge amount of time taken to get them.Awful market conditions for small cap companies and even worse to try and raise in mean many companies will see their share price Plummet and shareholders lose |
Posted at 06/3/2024 16:15 by npk2 I don't often agree with you bones, but I do on this one.The lower this goes the less wiggle room the bod has when negotiating the placing price.The lower the share price the more dilution for the shareholders.Not looking good. |
Posted at 28/2/2024 10:46 by dannymaz89 AstraZeneca has extended its drug delivery collaboration with #APTA Aptamer Group. The revised deal sets AstraZeneca up to build on research into the use of aptamer molecules to target renal cellsUpdate on this work soonYes that's right #APTA already in bed with Zeneca #RNS |
Posted at 15/12/2023 11:14 by ddonaldson2 Well bigruss when you call news every week yes of course you will be right eventually.... e.g. 3rd of November news next week looolbigruss1 - 03 Nov 2023 - 15:48:16 - 2117 of 4043 ☆☆ Aptamer Group - Novel Antibody Mimetics (Optimers) ☆☆ - APTA News next week could be tbh but I think they have been holding off due to placement shares being flipped personal I think its done I would prefer a slow and steady rise up to news results should be very good imo big deal being worked on with the 300k r&d funding massive multibag company this one buy and just hold i am A few others saying the seller is gone lmao bigruss1 - 01 Dec 2023 - 09:25:33 - 3596 of 4043 ☆☆ Aptamer Group - Novel Antibody Mimetics (Optimers) ☆☆ - APTA totally agree expecting the placement TR1 soon seller will be out still thing there holding off news so we have a clear path to 4p and mates can all get in .so clear if you think about it bigruss1 - 28 Nov 2023 - 10:52:36 - 3152 of 4043 ☆☆ Aptamer Group - Novel Antibody Mimetics (Optimers) ☆☆ - APTA anyone wondered why you can sell a lot of shares but to buy at a premium and not a lot is hard ..guess not because the clowns on here have nothing to invest ..don't have a real trading platform but you clown cant see it or know what's behind closed doors so the day will come and the clowns go back to there circus all dressed as little sad clown with little tears rolling down there little faces while there little pea size brains wondering why the RNS has rerated the company because that's what's going to happen here .and when that day does come soon there will be nothing the clowns 🤡 can do about it..so the last laugh will be all shareholders ..its not what you know but who bigruss1 - 26 Nov 2023 - 12:33:15 - 3064 of 4043 ☆☆ Aptamer Group - Novel Antibody Mimetics (Optimers) ☆☆ - APTA seller was active last week so expect i raise in share price this week and maybe a TR1 ..the company will be working hard to get them opinions for bod and staff first stop 4p |
Posted at 15/12/2023 10:31 by bigruss1 Thats were you are wrong ddonaldson2 ..Who call an rns right before the AGM on a deal ..I did look back on previous posts ..I have never really said anything about the share price apart from its going to recover at some point after the placement shares have cleared. .In fact i have called a few things right ..so I would class me the same plus i cant remember me ramping can you just try to keep it real .Aptamer group will do all the taking V RNS so no ramping needed here just sit back take a seat watch the company grow thats all i am doing.. The share price will catch up it always does |
Posted at 14/12/2023 09:13 by bigruss1 well it does seem there is some legacy placement shares still being churned but great rns 500k deal for a small market cap is very good the share price will correct its self at some point ..long term hold this one and multiple of the current share price in time.. |
Posted at 14/12/2023 07:11 by thehitman1 Aptamer Group signs material agreement with genetic medicines company- Optimer binders will be developed to support targeted genetic medicines to specific cell types- Contract comprises up to GBP553k in development fees for Aptamer Group Aptamer Group plc (AIM: APTA), the developer of novel Optimer (R) binders to enable innovation in the life sciences industry, announces that it has entered into a material agreement with a biotechnology company developing genetic medicines .Under the terms of the agreement, Aptamer Group will use its proprietary platform to discover Optimer binders to enable the specific targeting of genetic medicines to specific cell types. Aptamer Group will receive up to GBP553,000 in development fees for discovering and developing the Optimer binders. Work is expected to commence shortly subject to receiving target materials from the customer and is expected to be completed within the current financial year. |
Posted at 30/11/2023 11:07 by intoodeep "This is next generation tech so blue sky"Aptamer Group Plc Ord 0.1p is listed on the London Stock Exchange trading with ticker code APTA.L. It has a market capitalisation of £5.37m, with approximately 467.34m shares in issue. Over the last year, Aptamer Group share price has been traded in a range of 70.00, hitting a high of 71.00, and a low of 1.00. LOFL HONK HONK |
Posted at 23/11/2023 09:09 by intoodeep Aptamer Group Plc Ord 0.1p is listed on the London Stock Exchange trading with ticker code APTA.L. It has a market capitalisation of £5.26m, with approximately 467.34m shares in issue. Over the last year, Aptamer Group share price has been traded in a range of 70.00, hitting a high of 71.00, and a low of 1.00. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
